← Back to headlines

David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field

This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.

David Hung's Nuvation Bio wins FDA approval for Ibtrozi to challenge Pfizer, BMS and Roche in lung cancer field · NabkaNews